0% Complete
صفحه اصلی
/
4th international edition and 13th Iranian Conference on Bioinformatics
Innovative Biomarkers for Lung Cancer Classification and Prediction Using High-Dimensional Machine Learning: A Novel Approach to Targeted Therapies
نویسندگان :
Marzie Shadpirouz
1
Morteza Hadizadeh
2
Zahra Salehi
3
Maziyar Veisi
4
Reza Maddah
5
Mohammad Shirinpour
6
Kazem Abbaszadeh-Goudarzi
7
Kaveh Kavousi
8
1- University of Tehran
2- Kerman University of Medical Sciences
3- Tehran University of Medical Sciences
4- Shahrekord University
5- National Institute of Genetic Engineering and Biotechnology
6- Shahid Beheshti University
7- Sabzevar University of Medical Sciences
8- University of Tehran
کلمات کلیدی :
Lung adenocarcinoma،Machine learning،Precision Medicine،Drug repositioning
چکیده :
Lung adenocarcinoma (LUAD) represents the most prevalent pathological subtype of lung cancer. Unfortunately, a significant proportion of LUAD cases are detected at advanced stages, where the prognosis remains unfavorable. Therefore, our objective was to discover innovative biomarkers to enhance the diagnosis and treatment of early-stage LUAD and to develop targeted therapeutic strategies. In this study, two microarray datasets, GSE75037 and GSE32863, were sourced from the Gene Expression Omnibus (GEO) database for analysis. Data preprocessing and meta-analysis were conducted using the R statistical programming language. Feature selection was carried out through analysis of variance (ANOVA). To predict cancer stages, ordinal regression, ordinal tree, and ordinal forest models were developed, and their predictive performance was evaluated. Differentially expressed genes (DEGs) were identified and subjected to gene set enrichment analysis to uncover significant biological pathways. The validation and diagnostic accuracy of the DEGs were further examined using UALCAN and ROC curve analysis. Additionally, the selected genes were validated using an independent, comprehensive LUAD RNA-Seq dataset from The Cancer Genome Atlas (TCGA). To identify cell types associated with these genes, scRNA-Seq data from the GEO database (dataset GSE131907) including lung cancer and normal samples were analyzed. Differential gene expression was examined using the FindMarkers function from the Seurat package. Finally, potential therapeutic agents were identified through the DGIdb database, followed by molecular docking and molecular dynamics simulations to evaluate their potential efficacy as treatments. Analysis revealed that the top 40 differentially expressed genes (DEGs) were primarily associated with pathways involving drug metabolism via cytochrome P450, xenobiotic metabolism by cytochrome P450, and retinol metabolism. Among these, genes ADH1A, ADH1B, and F10 stood out due to their significant interactions within these pathways. Notably, a negative correlation was observed between the expression levels of these genes and patient survival rates. Additionally, their expression was significantly reduced in lung adenocarcinoma (LUAD) tissues compared to adjacent non-tumor tissues. The diagnostic potential of these genes was validated through ROC analysis, highlighting their ability to distinguish between cancerous and non-cancerous tissues. TCGA analysis showed that the selected genes were statistically significant across all stages, from I to IV .Based on the single-cell analysis, the ADH1B gene shows a significant differential expression in the Mesothelial cell type, an average log2 fold change of -6.1985, and an adjusted P-value of 0.0043. Moreover, drugs such as abacavir, rivaroxaban, and edoxaban tosylate demonstrated a strong binding affinity to these genes, suggesting their therapeutic relevance. These findings emphasize the value of leveraging bioinformatics and machine learning approaches to uncover new pathways for LUAD diagnosis and treatment, paving the way for more targeted and effective interventions.
لیست مقالات
لیست مقالات بایگانی شده
Evaluation of Penetration Efficiency of BR2 Peptide in Breast Cancer cell Lines Using computational Methods
Fatemeh Davari - Mahboobeh Zarrabi
Molecular Docking Analysis of Eugenol and Paclitaxel Targeting MRAS in Breast Cancer Therapy
Yaas Rowhani - Somayeh Reiisi
Immunoinformatics Approach to Epitope-Based Vaccine Design for H5N1 Avian Influenza Virus
Yasmin Alamdar
Investigating the Potential of Natural Small Molecules as BDNF Mimetics for Neurodegenerative Disease Treatment: A Molecular Docking Study with TrkB Receptor
Sevil Babashpour - Dina Morshedi - Farhang Aliakbari
Modeling and Predicting the Use of Medications Antiplatelets and ARBs Using Logistic Regression
Ahmad Aliyari Boroujeni - Pouya Joze Soleimani - Shima Soltani - Farzaneh Karamitanha
Attention based Graph Neural Network for Identifying Coding and Non-coding Breast Cancer Drivers
Bahar Mahdavi - Mitra Nemati Andavari - Mehdi Rajabizadeh - Mansoor Rezghi
Harnessing Deep Learning for Epitope Prediction in Immunoinformatics: A Novel Framework for Vaccine Design
Ali Rahmati hagh bonab - Hannaneh sadat Jalilzadeh
Comprehensive Computational Strategies for Multi-Target Drug Discovery in Inflammatory Bowel Disease Utilizing Bioactive Compounds
Pardis Mansouri - Pegah Mansouri - Sohrab Najafipour - Seyed Amin Kouhpayeh - Akbar Farjadfar - Esmaeil Behmard
Diabetes nephropathy indicators for early diagnosis
Sedigheh Momenzadeh - Masumeh Jalalvand - Reza Nedaeinia
Revealing disease subtypes and heterogeneity in common variable immunodeficiency through transcriptomic analysis
Mohammad Reza Zabihi - Zahra Moradi - Nima Safari - Zahra Salehi - Kaveh Kavousi
بیشتر
ثمین همایش، سامانه مدیریت کنفرانس ها و جشنواره ها - نگارش 42.7.0